0001567619-21-006209.txt : 20210312 0001567619-21-006209.hdr.sgml : 20210312 20210312160639 ACCESSION NUMBER: 0001567619-21-006209 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210310 FILED AS OF DATE: 20210312 DATE AS OF CHANGE: 20210312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kalra Balkrishan CENTRAL INDEX KEY: 0001768217 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33626 FILM NUMBER: 21737443 MAIL ADDRESS: STREET 1: 5 MARION AVENUE CITY: SHORT HILLS STATE: NJ ZIP: 07078 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Genpact LTD CENTRAL INDEX KEY: 0001398659 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 980533350 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 BUSINESS PHONE: 4412952244 MAIL ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 4 1 doc1.xml FORM 4 X0306 4 2021-03-10 0 0001398659 Genpact LTD G 0001768217 Kalra Balkrishan C/O GENPACT LLC 1155 AVENUE OF THE AMERICAS, 4TH FLOOR NEW YORK NY 10036 0 1 0 0 Senior Vice President Common Shares 2021-03-10 4 S 0 2147 42.3571 D 164823 D Common Shares 2021-03-11 4 S 0 1000 42.718 D 163823 D The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.350 to $42.375. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Includes 615 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 13, 2021. The reporting person currently holds a total of 6,074 shares under the ESPP. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.70 to $42.72. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. /s/ Thomas D. Scholtes as Attorney-in-fact for Balkrishan Kalra 2021-03-12